藥物濫用巴比妥（膠體金法快檢法）

廣州健侖生物科技有限公司

【包裝規(guī)格】 

1人份/袋、40人份/盒

本品采用競(jìng)爭(zhēng)抑制法和膠體金免疫層析技術(shù)，用于定性檢測(cè)人體尿液中的代謝物苯甲酰愛康寧，適用于藥物濫用的初步篩查。

產(chǎn)品特點(diǎn)：可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合，從二聯(lián)到十五聯(lián)都可以訂制。

廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

如需訂購(gòu)或者了解請(qǐng)以下或

mob： 楊   ： 

以下可以自由COMBO多聯(lián)檢測(cè)卡：

藥物濫用巴比妥（膠體金法快檢法）

更多產(chǎn)品說(shuō)明可通過(guò)下方的進(jìn)行了解w the test device, urine specimen, and/or controls to reach room temperature (15-30oC) prior to 

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【 市場(chǎng)部 】       楊永漢
【】 
【騰訊  】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室

Blue giardiasis, tsutsugamushi disease, whipworm disease, hookworm disease, tsutsugamushi disease, there are also some local intestinal helminthiasis, such as pig tapeworm, tapeworm and other tapeworm. Peters (1989) estimated that the number of locusts, whipworms, hookworms, and roundworms infected worldwide was 1.283 billion, 870 million, 716 million, and 360 million. In Asia, Africa, and Latin America, especially in agricultural areas, sewage irrigation and the use of fresh faeces are conducive to the spread of intestinal parasites; among malnourished residents, intestinal parasites have a more severe impact on their health. In the underdeveloped regions, especially in the rural poor, mixed infections of multiple parasites are common. The incidence of intestinal parasites has been considered as a basic measure of economic and cultural development in a region. Some people claim that parasitic diseases are "village disease" and "poor disease". It is a cause and effect of social economic and cultural backwardness. Therefore, parasitic diseases are one of the important reasons that hinder the development of third world countries. [9] In economically developed countries, parasitic diseases are also an important issue in public health. For example, the number of infections caused by Trichomonas vaginalis is estimated to be 2.5 million in the United States and 1 million in the United Kingdom. The infection with Giardia lamblia is particularly serious in the former Soviet Union, and the United States is almost universally popular. Many human-animal communicable parasitic diseases cause great losses to the livestock husbandry in economically developed areas and endanger the health of the population. In addition, some parasitic diseases that are not valued originally, such as toxoplasmosis, cryptosporidiasis, pneumocystis, etc., are associated with AIDS-related protozoa in some economically developed countries, including Japan, the Netherlands, the United Kingdom, France and the United States began to experience epidemics. [9] The current severity of the parasite's harm to humans is also manifested in the emergence of drug-resistant strains of P. falciparum and the complex problems of vector insect resistance. Therefore, with the chemical prevention and control of parasitic diseases and the control of vector insect chemistry, more new problems will emerge; as the range of human activities expands, many parasites that would otherwise have no or little contact with humans will inevitably emerge from the natural world. Bringing them to residential areas and entering the population creates new public health problems; human interactions are becoming more frequent, and parasites or vector arthropods that are otherwise harmful in other countries can be imported into the country and spread under certain conditions. The destruction of large-scale population flows and the balance of ecological environment caused by modern industrial and agricultural construction may also cause the prevalence of certain parasitic diseases; some modern medical measures